当前位置:主页 > 医学药学论文 >

免疫炎症在肺动脉高压中的研究进展

更新时间:2022-06-08
阅享价格80元 资料包括:原始论文 点击这里给我发消息QQ在线咨询
文档格式:doc/docx 全文字数:6500 温馨提示
以下仅列出文章摘要、提纲简介,如需获取全文阅读权限,或原创定制、长期合作,请随时联系。
微信QQ:312050216 点击这里给我发消息
扫一扫 扫一扫
免疫炎症在肺动脉高压中的研究进展

[摘要] :肺动脉高压是由于肺血管阻力增加,引起肺动脉压力升高,最终导致右心衰竭,引起死亡的一种心肺血管疾病。近年来,有许多研究表明,免疫炎症在肺动脉高压的形成及血管重构中起着关键作用。靶向免疫炎症治疗可能为肺动脉高压的治疗开辟新的途径。本文将对免疫炎症在肺动脉高压中的研究进展做一综述。

[关键词] 肺动脉高压;免疫炎症

Progress in research on immune inflammation in pulmonary arterial hypertension

[Abstract] :Pulmonary arterial hypertension(PAH)is a kind of cardiopulmonary vascular disease,which is caused by the increase of pulmonary vascular resistance, which leads to right heart failure and death. In recent years, many studies have shown that immune inflammation plays a key role in the formation of pulmonary arterial hypertension and vascular remodeling. Targeted immunoinflammatory therapy may open up a new way for the treatment of pulmonary arterial hypertension. This article will review the research progress of immuneinflammation in pulmonary arterial hypertension.

[Key words] Pulmonary arterial hypertension, immune inflammation